The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. (2026). Global Scientific Review, 48, 42-45. https://scienticreview.com/index.php/gsr/article/view/602